Coherus Biosciences Inc (CHRS)

08:50 AM

CHRS (Coherus BioSciences) 50-Day SMA : $0.92 (As of Nov. 30, 2024) - GuruFocus.com

08:50 AM

Nov 27, 2024

Coherus Management to Participate in the 2024 Citi Global Healthcare Conference - GlobeNewswire

Nov 27, 2024

Nov 27, 2024

Coherus BioSciences to Present at Citi Healthcare Conference's Oncology Panel | CHRS Stock News - StockTitan

Nov 27, 2024

Nov 23, 2024

Coherus BioSciences Inc (CHRS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - GuruFocus.com

Nov 23, 2024

Nov 20, 2024

Coherus BioSciences (CHRS) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 20, 2024

Nov 17, 2024

Coherus BioSciences, Inc. (NASDAQ:CHRS) Sees Significant Growth in Short Interest - MarketBeat

Nov 17, 2024

Nov 16, 2024

Los Angeles Capital Management LLC Has $967,000 Stock Position in Coherus BioSciences, Inc. (NASDAQ:CHRS) - MarketBeat

Nov 16, 2024

Nov 11, 2024

Coherus stock rallies 19% on Q3 earnings, Udenyca production update - MSN

Nov 11, 2024

Nov 08, 2024

Robert W. Baird Has Lowered Expectations for Coherus BioSciences (NASDAQ:CHRS) Stock Price - MarketBeat

Nov 08, 2024

Nov 08, 2024

Coherus BioSciences, Inc. (NASDAQ:CHRS) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Nov 07, 2024

Coherus BioSciences' (CHRS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Nov 07, 2024

Nov 07, 2024

Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Supply Challenges - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Coherus BioSciences Inc (CHRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada

Nov 07, 2024

Nov 06, 2024

Coherus BioSciences Reports Strong Q3 2024 Growth - TipRanks

Nov 06, 2024

Nov 06, 2024

Coherus BioSciences earnings beat by $0.15, revenue topped estimates - Investing.com Canada

Nov 06, 2024

Nov 06, 2024

Coherus BioSciences: Q3 Earnings Snapshot - San Antonio Express-News

Nov 06, 2024

Nov 06, 2024

Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 06, 2024

Nov 06, 2024

Investors Don't See Light At End Of Coherus BioSciences, Inc.'s (NASDAQ:CHRS) Tunnel And Push Stock Down 30% - Simply Wall St

Nov 06, 2024

Nov 05, 2024

Coherus BioSciences Q3 2024 Earnings Preview - MSN

Nov 05, 2024

Nov 05, 2024

CHRS stock touches 52-week low at $0.71 amid market challenges - Investing.com Australia

Nov 05, 2024

Nov 05, 2024

Coherus BioSciences Inc (CHRS) Q3 2024: Everything You Need to K - GuruFocus.com

Nov 05, 2024

Oct 31, 2024

Coherus BioSciences (CHRS) to Release Quarterly Earnings on Wednesday - MarketBeat

Oct 31, 2024

Oct 30, 2024

Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewswire

Oct 30, 2024

Oct 28, 2024

Brokerages Set Coherus BioSciences, Inc. (NASDAQ:CHRS) Price Target at $7.13 - MarketBeat

Oct 28, 2024

Oct 26, 2024

CHRS stock plunges to 52-week low, hitting $0.79 By Investing.com - Investing.com Canada

Oct 26, 2024

Oct 25, 2024

CHRS stock plunges to 52-week low, hitting $0.79 - Investing.com India

Oct 25, 2024

Oct 25, 2024

Warning: CHRS is at high risk of performing badly - MSN

Oct 25, 2024

Oct 23, 2024

Such Is The Power Of Coherus Biosciences Inc (NASDAQ: CHRS) - Stocks Register

Oct 23, 2024

Oct 22, 2024

Exclusive-Russia to use ship-to-ship LNG loadings to free up ice-class tankers By Reuters - Investing.com

Oct 22, 2024

Oct 19, 2024

Coherus BioSciences (NASDAQ:CHRS) Lowered to "Hold" at StockNews.com - MarketBeat

Oct 19, 2024

Oct 18, 2024

CHRS stock touches 52-week low at $0.85 amid market challenges - Investing.com India

Oct 18, 2024

Oct 17, 2024

CHRS stock touches 52-week low at $0.85 amid market challenges By Investing.com - Investing.com South Africa

Oct 17, 2024

Oct 17, 2024

Coherus BioSciences, Inc. (NASDAQ:CHRS) Sees Significant Increase in Short Interest - MarketBeat

Oct 17, 2024

Oct 15, 2024

How should investors view Coherus Biosciences Inc (CHRS)? - US Post News

Oct 15, 2024

Oct 15, 2024

Coherus Biosciences Inc Inc. (CHRS) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Oct 15, 2024

Oct 15, 2024

StockNews.com Upgrades Coherus BioSciences (NASDAQ:CHRS) to “Buy” - Defense World

Oct 15, 2024